Table 2 Outcomes of infants (≤60 days of life): results of the mixed effect regression models.

From: Severity of respiratory syncytial virus through the COVID-19 pandemic among infants aged ≤2 months: a secondary analysis of the IRIDE cohort study

Characteristics

Period

Odds ratio/ mean difference

IC 95%

p

Oxygen supplementation

2021–2022

2.157

1.330–3.497

0.002

2022–2023

2.030

1.162–3.549

0.013

Length of oxygen supplementation

2021–2022

1.068

0.503–1.633

<0.001

2022–2023

1.042

0.403–1.680

0.001

Non invasive ventilation

2021–2022

2.550

1.665–3.906

<0.001

2022–2023

3.700

2.262–6.053

<0.001

Invasive ventilation

2021–2022

0.407

0.123 - 1.351

0.142

2022–2023

1.656

0.624–4.392

0.311

Length of hospital stay

2021–2022

−0.255

–0.866 to 0.356

0.413

2022–2023

0.231

–0.459 to 0.921

0.511

Admission to the intensive care unit

2021–2022

1.329

0.801–2.206

0.271

2022–2023

1.344

0.740–2.440

0.331

Length of stay in the intensive care unit

2021–2022

0.032

–0.451 to 0.515

0.897

2022–2023

0.162

–0.389 to 0.712

0.564

  1. Study periods (reference 2018–19) were the predictive variables.
  2. Significant p-values highlighted in bold.